Insider

John F Crowley Insider Trading Activity

Every SEC Form 4 transaction reported by John F Crowley, sourced directly from SEC EDGAR and updated as new filings are accepted.

Latest filing:

Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.

Quick Answer

Is John F Crowley buying or selling?

John F Crowley reported 1 open-market buys ($48.6K) and 105 sells ($27.6M) across 106 Form 4 filings at 3 companies — a net selling position of $27.6M.

Source: SEC EDGAR Form 4

What stands out

  • John F Crowley has reported Form 4 transactions at 3 companies; the most active, AMICUS THERAPEUTICS, INC. (FOLD), accounts for 103 of 106 filings (97%).
  • The most recent Form 4 was accepted on Mar 15, 2024 (2 years ago).
  • No open-market purchases or sales were reported in the last 12 months.

Key Statistics (as of Mar 15, 2024)

Total Form 4 filings
106
SEC EDGAR
Companies
3
Buys (1)
$48.6K
Sells (105)
$27.6M

Insider sentiment

Net selling

Net insider flow of $27.6M in net selling, filed between Jan 2, 2018 – Mar 15, 2024.

Companies John F Crowley files for

#CompanyForm 4 filings
1FOLDAMICUS THERAPEUTICS, INC.103
2NTLAIntellia Therapeutics, Inc.2
3TRDAEntrada Therapeutics, Inc.1

Recent John F Crowley transactions

DateTickerRoleTypeSharesValueFiling
Mar 15, 2024FOLDExecutive ChairmanSale31.6K$431.5KSEC ↗
Mar 5, 2024FOLDExecutive ChairmanSale29.2K$389.5KSEC ↗
Feb 20, 2024FOLDExecutive ChairmanSale31.6K$436.6KSEC ↗
Feb 6, 2024FOLDExecutive ChairmanSale31.6K$398.9KSEC ↗
Jan 18, 2024FOLDExecutive ChairmanSale31.6K$404.1KSEC ↗
Dec 19, 2023FOLDExecutive ChairmanSale6.0K$76.5KSEC ↗
Dec 5, 2023FOLDExecutive ChairmanSale6.0K$67.0KSEC ↗
Nov 17, 2023FOLDExecutive ChairmanSale6.0K$65.5KSEC ↗
Nov 3, 2023FOLDExecutive ChairmanSale6.0K$66.3KSEC ↗
Oct 18, 2023FOLDExecutive ChairmanSale6.0K$63.4KSEC ↗
Oct 4, 2023FOLDExecutive ChairmanSale6.0K$68.0KSEC ↗
Sep 18, 2023FOLDExecutive ChairmanSale6.0K$79.0KSEC ↗
Sep 6, 2023FOLDExecutive ChairmanSale6.0K$78.4KSEC ↗
Aug 16, 2023FOLDExecutive ChairmanSale6.0K$78.7KSEC ↗
Aug 3, 2023FOLDExecutive ChairmanSale6.0K$80.7KSEC ↗
Jul 6, 2023FOLDExecutive ChairmanSale6.0K$74.4KSEC ↗
Jun 20, 2023FOLDExecutive ChairmanSale6.0K$78.8KSEC ↗
Jun 5, 2023FOLDExecutive ChairmanSale6.0K$68.7KSEC ↗
May 17, 2023FOLDExecutive ChairmanSale6.0K$67.6KSEC ↗
May 3, 2023FOLDExecutive ChairmanSale6.0K$71.3KSEC ↗
Apr 19, 2023FOLDExecutive ChairmanSale6.0K$70.5KSEC ↗
Apr 6, 2023FOLDExecutive ChairmanSale6.0K$67.8KSEC ↗
Mar 17, 2023FOLDExecutive ChairmanSale6.0K$68.5KSEC ↗
Mar 3, 2023FOLDExecutive ChairmanSale6.0K$81.1KSEC ↗
Feb 16, 2023FOLDExecutive ChairmanSale6.0K$78.2KSEC ↗

Showing the 25 most recent filings of 106. Screen every filing.

John F Crowley insider trading FAQ

Is John F Crowley buying or selling?

Across 106 SEC Form 4 filings, John F Crowley reported 1 open-market purchases totaling $48.6K and 105 sales totaling $27.6M — a net selling position of $27.6M.

Which companies does John F Crowley file Form 4s for?

John F Crowley has reported insider transactions at 3 companies, most often AMICUS THERAPEUTICS, INC. (FOLD), Intellia Therapeutics, Inc. (NTLA), Entrada Therapeutics, Inc. (TRDA).

How far back does John F Crowley's filing history go?

Trabud holds John F Crowley's SEC Form 4 filings from Jan 2, 2018 – Mar 15, 2024, sourced directly from SEC EDGAR.

Where does Trabud get John F Crowley's insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Track John F Crowley and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener